Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
CDMO business delivered high-teen revenue growth for 9MFY25 driven by continued traction in the on-patent commercial manufacturing and generic API business
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
EBITDA grew by 31% YoY with EBITDA margin of 11%, a YoY improvement of over 170bps vs. Q1FY24
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Subscribe To Our Newsletter & Stay Updated
